プロテイナーゼKの世界市場：市場規模・シェア・動向分析 (形状別・治療領域別・用途別・最終用途別・地域別・セグメント別、2025年～2030年)

プロテイナーゼK市場の成長と動向：

世界のプロテイナーゼKの市場規模は2030年に78億4,000万米ドルに達し、2025年から2030年にかけてCAGR 8.5%で成長すると予測されます。市場成長の原動力となっているのは、分子診断技術とそれに関連する体外診断用酵素における幅広い用途です。プロテイナーゼKはPCRやNGSの補助剤として利用できます。 遺伝子発現プロファイリングとqPCRによる標的パネルが、病理検査室におけるNGSシーケンスの最も頻繁な用途であることに変わりはありません。

臨床的に開発された様々な治療法とともに、個別化医療におけるNGSの応用が増加していることは、プロテイナーゼKの市場に有利に働くと思われます。遺伝子発現プロファイリングとqPCRによる標的パネルが、病理検査室におけるNGSシーケンスの最も頻繁な使用法です。さらに、NGSシーケンスの価格低下により、NSC技術の利用が拡大しています。したがって、NGS診断技術に対する需要の高まりが市場成長を後押しすると予想されます。

さらに、細胞分離手順の採用が増加していることも、市場成長に寄与する主な要因の1つです。企業は市場での競争力を得るために持続可能な技術の構築に着手しています。例えば、2022年4月、Levitas Bio社は既存の細胞分離用プラットフォームの次世代版を発表しました。新バージョンは、研究者の実験を最大16倍まで拡大し、1回あたり約4,000万個の細胞を処理することを支援すると期待されています。

さらに、POCベースの診断薬の使用は世界的に著しく増加しています。感染症の症状やその予防法を特定することを目的とした公衆啓発キャンペーンは、病気のトランスミッションをコントロールする上で重要な役割を果たしています。このように、患者の関心の高まりがPOCの需要増につながっています。例えば、2020年5月、Specific High Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK) 診断法によるCOVID-19のPOC検査に関する研究が発表されました。研究者らは、プロテイナーゼKを含むLucigen社のQuickExtractを使用しました。このように、POC診断に対する需要の高まりとPOC診断検査におけるプロテイナーゼKの有用性は、市場の成長を促進すると予想されます。

さらに、分子生物学やその他の分野でのプロテイナーゼKの用途拡大が、近い将来に有利な機会を生み出すと期待されています。プロテイナーゼKは、食品・飲食品業界で品質基準を維持するために使用されています。食品メーカーは、製造に使用する原材料の品質維持に努めています。さらに、プロテイナーゼKは加工食品からDNAを抽出する際の細胞溶解にも使用されます。この酵素はまた、幅広い分子生物学的アッセイにも応用されています。したがって、プロテイナーゼKのこのような用途は、予測期間中に市場を牽引すると予想されます。

プロテイナーゼK市場の概要

• 形状別では、粉末セグメントが2024年に圧倒的なシェアを占めました。粉末の利点には、保存期間が長い、出荷コストが安い、安定性が高いなどがあります。したがって、このような利点により粉末の採用が増加すると予想されます。
• 治療領域別では、感染症分野が2024年に最大のシェアを獲得しました。低・中所得諸国における感染症罹患率の増加とともに、迅速分子検査におけるプロテイナーゼKの存在が、低資源環境でも操作しやすい製品の開発を促進すると予測されます。これが市場の成長を加速させています。
• 用途別では、ゲノムDNAとRNAの分離・精製分野が2024年に最大のシェアを占めました。がんや希少疾患における個別化治療のニーズが高まる中、DNAやRNAの単離に対する需要は増加傾向にあり、同様の動向は市場にも反映されると予想されます。
• 最終用途別では、バイオテクノロジー企業が2024年に主要収益シェアを占めました。これは、バイオテクノロジー企業の臨床および前臨床研究をサポートするためのインサイチュハイブリダイゼーション (ISH) 技術の応用が増加しているためです。
• アジア太平洋は、ゲノミクス研究を促進するための様々な政府のイニシアチブと相まって、シーケンス技術のアプリケーションの増加により、将来的に大きく成長すると予測されています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 プロテイナーゼK市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• プロテイナーゼK市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 プロテイナーゼK市場：形状別の推定と動向分析

• 市場シェア：形状別 (2024年・2030年)
• セグメント別のダッシュボード
• 世界のプロテイナーゼK市場の展望：形状別
• 市場規模の予測と動向分析：形状別 (2018～2030年)
  • 粉末
  • 液体

第5章 プロテイナーゼK市場：治療領域別の推定と動向分析

• 市場シェア：治療領域別 (2024年・2030年)
• セグメント別のダッシュボード
• 世界のプロテイナーゼK市場の展望：治療領域別
• 市場規模の予測と動向分析：治療領域別 (2018～2030年)
  • 感染症
  • 糖尿病
  • 腫瘍学
  • 心臓病学
  • 腎臓学
  • 自己免疫疾患
  • 神経学
  • その他

第6章 プロテイナーゼK市場：用途別の推定と動向分析

• 市場シェア：用途別 (2024年・2030年)
• セグメント別のダッシュボード
• 世界のプロテイナーゼK市場の展望：用途別
• 市場規模の予測と動向分析：用途別 (2018～2030年)
  • ゲノムDNA・RNAの分離と精製
  • in situ ハイブリダイゼーション
  • ミトコンドリアの分離

第7章 プロテイナーゼK市場：最終用途別の推定と動向分析

• 市場シェア：最終用途別 (2024年・2030年)
• セグメント別のダッシュボード
• 世界のプロテイナーゼK市場の展望：最終用途別
• 市場規模の予測と動向分析：最終用途別 (2018～2030年)
  • CMO (医薬品開発業務受託機関)
  • 学術機関
  • バイオテクノロジー企業
  • 診断検査室

第8章 プロテイナーゼK市場：地域の推定と動向分析

• 市場シェア：形状別 (2024年・2030年)
• 地域別の市場ダッシュボード
• 世界市場のスナップショット：地域別
• 市場規模の予測と動向分析 (2018～2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 最新動向と影響分析：主要な市場参入企業別
• 企業/競合の分類
• ベンダー情勢
  • 市場シェア分析：主要企業別 (2024年)
  • Merck KGaA
  • QIAGEN
  • Thermo Fisher Scientific, Inc
  • F. Hoffmann-La Roche Ltd
  • Abcam plc
  • Agilent Technologies, Inc
  • Biocatalysts
  • Minerva Biolabs GmbH
  • Promega Corporation
  • Takara Bio Inc
  • New England Biolabs
  • MP Biomedicals

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 4 Global Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 5 Global Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 6 Global Proteinase K Market, by End use, 2018 - 2030 (USD Million)
• Table 7 Global Proteinase K Market, by Region, 2018 - 2030 (USD Million)
• Table 8 North America Proteinase K Market, by Country, 2018 - 2030 (USD Million)
• Table 9 North America Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 10 North America Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 11 North America Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 12 North America Proteinase K Market, by End use, 2018 - 2030 (USD Million)
• Table 13 U.S. Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 14 U.S. Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 15 U.S. Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 16 U.S. Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 17 Canada Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 18 Canada Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 19 Canada Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 20 Canada Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 21 Mexico Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 22 Mexico Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 23 Mexico Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 24 Mexico Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 25 Europe Proteinase K Market, by Country, 2018 - 2030 (USD Million)
• Table 26 Europe Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 27 Europe Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 28 Europe Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 29 Europe Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 30 Germany Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 31 Germany Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 32 Germany Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 33 Germany Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 34 UK Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 35 UK Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 36 UK Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 37 UK Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 38 France Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 39 France Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 40 France Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 41 France Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 42 Italy Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 43 Italy Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 44 Italy Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 45 Italy Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 46 Spain Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 47 Spain Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 48 Spain Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 49 Spain Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Proteinase K Market, by Country, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 53 Asia Pacific Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 54 Asia Pacific Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 55 China Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 56 China Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 57 China Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 58 China Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 59 Japan Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 60 Japan Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 61 Japan Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 62 Japan Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 63 India Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 64 India Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 65 India Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 66 India Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 67 Singapore Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 68 Singapore Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 69 Singapore Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 70 Singapore Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 71 Australia Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 72 Australia Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 73 Australia Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 74 Australia Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 75 Latin America Proteinase K Market, by Country, 2018 - 2030 (USD Million)
• Table 76 Latin America Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 77 Latin America Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 78 Latin America Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 79 Latin America Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 80 Brazil Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 81 Brazil Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 82 Brazil Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 83 Brazil Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 84 Argentina Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 85 Argentina Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 86 Argentina Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 87 Argentina Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 88 Middle East & Africa Proteinase K Market, by Country, 2018 - 2030 (USD Million)
• Table 89 Middle East & Africa Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 90 Middle East & Africa Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 91 Middle East & Africa Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 92 Middle East & Africa Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 93 South Africa Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 94 South Africa Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 95 South Africa Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 96 South Africa Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 97 Saudi Arabia Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 98 Saudi Arabia Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 99 Saudi Arabia Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 100 Saudi Arabia Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 101 UAE Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 102 UAE Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 103 UAE Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 104 UAE Proteinase K Market, End use, 2018 - 2030 (USD Million)
• Table 105 Kuwait Proteinase K Market, by Form, 2018 - 2030 (USD Million)
• Table 106 Kuwait Proteinase K Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table 107 Kuwait Proteinase K Market, by Application, 2018 - 2030 (USD Million)
• Table 108 Kuwait Proteinase K Market, End use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Proteinase K Market Segmentation
• Fig. 8 Market Snapshot, 2024
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 Global Proteinase K Market: Form Movement Analysis
• Fig. 16 Global Proteinase K Market, for Powder, 2018 - 2030 (USD Million)
• Fig. 17 Global Proteinase K Market, for Liquid, 2018 - 2030 (USD Million)
• Fig. 18 Global Proteinase K Market: Therapeutic Area Movement Analysis
• Fig. 19 Global Proteinase K Market, for Infectious diseases, 2018 - 2030 (USD Million)
• Fig. 20 Global Proteinase K Market, for Diabetes, 2018 - 2030 (USD Million)
• Fig. 21 Global Proteinase K Market, for Oncology, 2018 - 2030 (USD Million)
• Fig. 22 Global Proteinase K Market, for Cardiology, 2018 - 2030 (USD Million)
• Fig. 23 Global Proteinase K Market, for Nephrology, 2018 - 2030 (USD Million)
• Fig. 24 Global Proteinase K Market, for Autoimmune diseases, 2018 - 2030 (USD Million)
• Fig. 25 Global Proteinase K Market, for Neurology, 2018 - 2030 (USD Million)
• Fig. 26 Global Proteinase K Market, for Others, 2018 - 2030 (USD Million)
• Fig. 27 Global Proteinase K Market: Application Movement Analysis
• Fig. 28 Global Proteinase K Market, for Isolation and Purification of Genomic DNA & RNA, 2018 - 2030 (USD Million)
• Fig. 29 Global Proteinase K Market, for In Situ Hybridization, 2018 - 2030 (USD Million)
• Fig. 30 Global Proteinase K Market, for Mitochondria isolation, 2018 - 2030 (USD Million)
• Fig. 31 Global Proteinase K Market: End use Movement Analysis
• Fig. 32 Global Proteinase K Market, for Contract Research Organization, 2018 - 2030 (USD Million)
• Fig. 33 Global Proteinase K Market, for Academic Institutes, 2018 - 2030 (USD Million)
• Fig. 34 Global Proteinase K Market, for Biotechnology Companies, 2018 - 2030 (USD Million)
• Fig. 35 Global Proteinase K Market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
• Fig. 36 Regional Marketplace: Key Takeaways
• Fig. 37 Regional Outlook, 2024 & 2030
• Fig. 38 Global Biochips Market: Region Movement Analysis
• Fig. 39 North America Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 40 U.S. Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 41 Canada Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 42 Mexico Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 43 Europe Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 44 Germany Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 45 UK Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 46 France Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 47 Italy Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 48 Spain Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 49 Asia Pacific Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 50 Japan Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 51 China Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 52 India Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 53 Singapore Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 54 Australia Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 55 Latin America Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 56 Brazil Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 57 Argentina Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 58 Middle East and Africa Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 59 South Africa Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 60 Saudi Arabia Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 61 UAE Proteinase K Market, 2018 - 2030 (USD Million)
• Fig. 62 Kuwait Proteinase K Market, 2018 - 2030 (USD Million)

Proteinase K Market Growth & Trends:

The global proteinase K market size is expected to reach USD 7.84 billion in 2030 and is expected to grow at a CAGR of 8.5% from 2025 to 2030. The market growth is fueled by a broad range of applications in molecular diagnostic techniques and their associated enzymes for IVD. Proteinase K can be utilized as a supplement in PCR and NGS. Increasing applications of NGS in personalized medicine along with various clinically developed therapies are likely to favor the market for proteinase K. Gene expression profiling and targeted panels via qPCR remain the two most frequent uses for NGS sequences in a pathology lab. In addition, a decline in the price of NGS sequencing has expanded the use of NSC technologies. Therefore, the growing demand for NGS diagnostic techniques is expected to boost the market growth.

In addition, the rising adoption of cell separation procedures is one of the major factors contributing to the market growth. Companies have initiated building sustainable technologies to gain a competitive edge in the market. For instance, in April 2022, Levitas Bio introduced the next generation of its existing platform for cell separation. The new version is expected to assist researchers in scaling their experiments up to 16X and process around 40 million cells per run.

Moreover, the usage of POC-based diagnostics is increasing significantly globally. Public awareness campaigns aimed at identifying the symptoms of infectious diseases and ways to prevent them play an important role in controlling disease transmission. Thus, increased patient attention has led to a rise in demand for POC. For instance, in May 2020, a study on POC testing for COVID-19 through Specific High Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK) diagnostics was published. The researchers used QuickExtract by Lucigen, which contains Proteinase K. Thus, the growing demand for POC diagnostics and the utility of proteinase K in POC diagnostic tests are expected to fuel market growth.

Furthermore, growing applications of proteinase K in molecular biology and other fields are expected to create lucrative opportunities in the near future. Proteinase K is used in the food and beverage industry to maintain quality standards. Food manufacturers work to maintain the quality of raw materials used for manufacturing. In addition, proteinase K is used for cell lysis during DNA extraction from processed foods. The enzyme also finds application in a wide range of molecular biology assays. Hence, such applications of proteinase K are anticipated to drive the market during the forecast period.

Proteinase K Market Report Highlights:

• By form, the powder segment accounted for a dominant share in 2024. Advantages of powder form include long shelf-life, inexpensive shipment, and high stability. Thus, such advantages are expected to increase the adoption of powder
• By therapeutic area, the infectious diseases segment captured the largest share in 2024. Presence of proteinase K in the rapid molecule testing along with increasing incidence of infectious diseases in low- to mid-income countries is anticipated to encourage players to develop products that are easy to operate in a low-resource setting. This is, in turn, accelerating the market growth
• By application, the isolation and purification of genomic DNA and RNA segment held the largest share in 2024. With the emerging need for personalized treatment in cancer and rare diseases, the demand for DNA or RNA isolation is anticipated to witness upward trends and similar trends will be reflected in the market
• By end-use, biotechnology companies held a leading revenue share in 2024. This is due to an increase in the application of In Situ Hybridization (ISH) techniques to support clinical and preclinical studies for biotechnology companies
• Asia Pacific is projected to grow considerably in the future owing to increasing applications of sequencing technology, coupled with various government initiatives to promote genomics research.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Form
  • 1.2.2. Therapeutic area
  • 1.2.3. End use
  • 1.2.4. Application
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Form outlook
  • 2.2.2. Therapeutic area outlook
  • 2.2.3. End use outlook
  • 2.2.4. Application outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Proteinase K Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growth in Molecular Diagnostics
    • 3.2.1.2. Rise in Genomic Research
    • 3.2.1.3. Increasing Adoption in Forensic Science
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Availability of Alternative Enzymes
• 3.3. Proteinase K Market Analysis Tools
  • 3.3.1. Industry Analysis -Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Proteinase K Market: Form Estimates & Trend Analysis

• 4.1. Form Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Proteinase K Market by Form Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Powder
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 4.4.2. Liquid
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Proteinase K Market: Therapeutic Area Estimates & Trend Analysis

• 5.1. Therapeutic Area Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Proteinase K Market by Therapeutic Area Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Infectious Diseases
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 5.4.2. Diabetes
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Oncology
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Cardiology
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Nephrology
    • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Autoimmune Diseases
    • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.7. Neurology
    • 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.8. Others
    • 5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Proteinase K Market: Application Estimates & Trend Analysis

• 6.1. Application Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Proteinase K Market by Application Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Isolation and Purification of Genomic DNA & RNA
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 6.4.2. In Situ Hybridization
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Mitochondria Isolation
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Proteinase K Market: End Use Estimates & Trend Analysis

• 7.1. End Use Market Share, 2024 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Proteinase K Market by End Use Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4.1. Contract Research Organization
    • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
  • 7.4.2. Academic Institutes
    • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Biotechnology Companies
    • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Diagnostic Laboratories
    • 7.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Proteinase K Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory framework/ reimbursement structure
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory framework/ reimbursement structure
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory framework/ reimbursement structure
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory framework/ reimbursement structure
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory framework/ reimbursement structure
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory framework/ reimbursement structure
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory framework/ reimbursement structure
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory framework/ reimbursement structure
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory framework/ reimbursement structure
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Regulatory framework/ reimbursement structure
    • 8.9.1.3. Competitive scenario
    • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory framework/ reimbursement structure
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory framework/ reimbursement structure
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory framework/ reimbursement structure
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. Key company market share analysis, 2024
  • 9.3.2. Merck KGaA
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Product benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. QIAGEN
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. Thermo Fisher Scientific, Inc
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. F. Hoffmann-La Roche Ltd
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Abcam plc
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Agilent Technologies, Inc
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Biocatalysts
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Minerva Biolabs GmbH
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Promega Corporation
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Takara Bio Inc
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. New England Biolabs
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. MP Biomedicals
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives